MSB 3.19% 97.0¢ mesoblast limited

Ann: Remestemcel-L Improves Outcomes in Inflammatory Lung Disease, page-3

  1. 942 Posts.
    lightbulb Created with Sketch. 298
    B-o-o-m !!!
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.